Symptoms Treatment Drug Development Treatment Options Medical Evaluation White House Medical Unit Progression of Motor Symptoms Lixisenatide Doctor Visits GLP-1R Agonists Causes Psilocybin Clinical Trials for Parkinson's Disease Clinical Trials Medical School Antibody Treatment Movement Disorders Specialist Medical Treatment Treatment of Parkinson's Disease Specialist Visits Neurologist Cure Research Surgery Deep Brain Stimulation GLP-1 Drugs for Parkinson's Disease Diagnosis Stem Cell Therapy Levodopa Stool Transplant Dr. Kevin Cannard Medical Records Current Treatments Medical Ethics Research Specialist Symptom Management Research Findings Aging Neurological Specialists Alpha Synuclein Exenatide Pramipexole
Want to see what podcasts are saying about this topic? Search across 140K+ podcasts. Explore Radar
Peer‑reviewed preclinical results show a trapidil‑derived compound preserved levodopa’s motor programs, lowered involuntary movements, prompting Sinopia to complete toxicology before planned first‑in‑human trials next year.
